Altered glycosylation is commonly observed in colorectal cancer. In vitro models are frequently used to study this cancer but little is known about the differences that may exist between these model cell systems and tumour tissue. We have compared the membrane protein glycosylation of five colorectal cancer cell lines (SW1116, SW480, SW620, SW837, LS174T) with epithelial cells from colorectal tumours using liquid chromatography tandem mass spectrometry. Remarkably, there were five abundant O-glycans in the tumour cells that were undetected in the low-mucin producing cell lines, although two were found in the mucinous LS174T cells. The O-glycans included the well-known glycan cancer marker, sialyl-Tn, which has been associated with mucins. U...
The surface of eukaryotic cells contains a very dense layer of oligosaccharides called glycans that ...
Colorectal cancer (CRC) is the third most common malignancy, worldwide. CRC follows a gradual progre...
Colorectal cancer is the third most common cancer worldwide with an annual incidence of ~1 million c...
Altered glycosylation is commonly observed in colorectal cancer. In vitro models are frequently used...
Altered glycosylation is commonly observed in colorectal cancer. In vitro models are frequently used...
Thesis by publication.Includes bibliographical references.1. Introduction -- 2. Comprehensive glycom...
Advances in colorectal cancer (CRC) diagnosis will be enhanced by development of more sensitive and ...
Alterations in protein glycosylation in colorectal cancer (CRC) have been extensively studied using ...
Advances in colorectal cancer (CRC) diagnosis will be enhanced by development of more sensitive and ...
Alterations in glycosylation are seen in many types of cancer, including colorectal cancer (CRC). Gl...
Glycans on proteins and lipids are known to alter with malignant transformation. The study of these ...
Glycans on proteins and lipids are known to alter with malignant transformation. The study of these ...
Glycomics may assist in uncovering the structure-function relationships of protein glycosylation and...
A multi-glycomic method for characterizing the glycocalyx was employed to identify the difference be...
The choice for adjuvant chemotherapy in stage II colorectal cancer is controversial as many patients...
The surface of eukaryotic cells contains a very dense layer of oligosaccharides called glycans that ...
Colorectal cancer (CRC) is the third most common malignancy, worldwide. CRC follows a gradual progre...
Colorectal cancer is the third most common cancer worldwide with an annual incidence of ~1 million c...
Altered glycosylation is commonly observed in colorectal cancer. In vitro models are frequently used...
Altered glycosylation is commonly observed in colorectal cancer. In vitro models are frequently used...
Thesis by publication.Includes bibliographical references.1. Introduction -- 2. Comprehensive glycom...
Advances in colorectal cancer (CRC) diagnosis will be enhanced by development of more sensitive and ...
Alterations in protein glycosylation in colorectal cancer (CRC) have been extensively studied using ...
Advances in colorectal cancer (CRC) diagnosis will be enhanced by development of more sensitive and ...
Alterations in glycosylation are seen in many types of cancer, including colorectal cancer (CRC). Gl...
Glycans on proteins and lipids are known to alter with malignant transformation. The study of these ...
Glycans on proteins and lipids are known to alter with malignant transformation. The study of these ...
Glycomics may assist in uncovering the structure-function relationships of protein glycosylation and...
A multi-glycomic method for characterizing the glycocalyx was employed to identify the difference be...
The choice for adjuvant chemotherapy in stage II colorectal cancer is controversial as many patients...
The surface of eukaryotic cells contains a very dense layer of oligosaccharides called glycans that ...
Colorectal cancer (CRC) is the third most common malignancy, worldwide. CRC follows a gradual progre...
Colorectal cancer is the third most common cancer worldwide with an annual incidence of ~1 million c...